[1]
T. Inoue, H. Sano, T. Mizushima, H. Nishie, H. Iwasaki, and F. Okumura, “A Case of Duodenal Neuroendocrine Carcinoma Treated with Amrubicin as Second-line Chemotherapy”, JGLD, vol. 24, no. 3, pp. 379-382, Sep. 2015.